4.7 Article

Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort

期刊

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 54, 期 5, 页码 689-698

出版社

WILEY
DOI: 10.1111/apt.16488

关键词

-

资金

  1. Canadian Cancer Society
  2. Canadian Frailty Network
  3. Canadian Institutes of Health Research
  4. Canadian Medical Protective Association
  5. Green Shield Canada Foundation
  6. Natural Sciences and Engineering Research Council of Canada
  7. Ontario Health
  8. St. Michael's Hospital Association Innovation Fund
  9. University of Toronto
  10. Vector Institute

向作者/读者索取更多资源

Liver disease is a growing burden on population health globally, with liver disease patients in Toronto-area hospitals having higher mortality rates and resource use compared to common cardio-respiratory conditions such as heart failure, COPD, and pneumonia. Re-evaluation of approaches to caring for inpatients with liver disease is necessary.
Background Liver disease is an increasing burden on population health globally. Aims To characterise burden of liver disease among general internal medicine inpatients at seven Toronto-area hospitals and compare it to other common medical conditions. Methods Data from April 2010 to October 2017 were obtained from hospitals participating in the GEMINI collaborative. Using these cohort data from hospital information systems linked to administrative data, we defined liver disease admissions using most responsible discharge diagnoses categorised according to international classification of diseases, 10th Revision-enhanced Canadian version (ICD-10-CA). We identified admissions for heart failure, chronic obstructive pulmonary disease (COPD) and pneumonia as comparators. We calculated standardised mortality ratios (SMRs) as the ratio of observed to expected deaths. Results Among 239 018 discharges, liver disease accounted for 1.7% of most responsible discharge diagnoses. Liver disease was associated with marked premature mortality, with SMR of 8.84 (95% CI 8.06-9.67) compared to 1.06 (95% CI 0.99-1.12) for heart failure, 1.05 (95% CI 0.96-1.15) for COPD and 1.28 (95% CI 1.20-1.37) for pneumonia. The majority of deaths were among patients younger than 65 years (57.7%) compared to 3.3% in heart failure, 5.6% in COPD and 10.7% in pneumonia. Liver disease patients presented with worse Laboratory-Based Acute Physiology Scores, were more frequently admitted to the intensive care unit (14.4%), incurred higher average total costs (median $6723 CAD), had higher in-hospital mortality (11.4%), and were more likely to be a readmission from 30 days prior (19.8%). Non-alcoholic fatty liver disease admissions increased from 120 in 2011-2012 to 215 in 2016-2017 (P < 0.01). Conclusion In Canada's largest urban centre, liver disease admissions resulted in premature morbidity and mortality with higher resource use compared to common cardio-respiratory conditions. Re-evaluation of approaches to caring for inpatients with liver disease is timely and justified.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据